These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28336290)

  • 41. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis.
    Tang K; Xu H
    Sci Rep; 2015 May; 5():10272. PubMed ID: 25974855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
    Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
    Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
    Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma.
    Cochetti G; Cari L; Nocentini G; Maulà V; Suvieri C; Cagnani R; Rossi De Vermandois JA; Mearini E
    Sci Rep; 2020 Dec; 10(1):21290. PubMed ID: 33277569
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a microRNA panel for clear-cell kidney cancer.
    Juan D; Alexe G; Antes T; Liu H; Madabhushi A; Delisi C; Ganesan S; Bhanot G; Liou LS
    Urology; 2010 Apr; 75(4):835-41. PubMed ID: 20035975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
    Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
    Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA profiles in serum samples from patients with stable cirrhosis and miRNA-21 as a predictor of transplant-free survival.
    Amaral AED; Rode MP; Cisilotto J; Silva TED; Fischer J; Matiollo C; Morais Rateke EC; Narciso-Schiavon JL; Schiavon LL; Creczynski-Pasa TB
    Pharmacol Res; 2018 Aug; 134():179-192. PubMed ID: 29935272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression.
    Ma Q; Peng Z; Wang L; Li Y; Wang K; Zheng J; Liang Z; Liu T
    Int J Oncol; 2016 Dec; 49(6):2589-2599. PubMed ID: 27779660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clear cell renal cell carcinoma associated microRNA expression signatures identified by an integrated bioinformatics analysis.
    Chen J; Zhang D; Zhang W; Tang Y; Yan W; Guo L; Shen B
    J Transl Med; 2013 Jul; 11():169. PubMed ID: 23841900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma.
    Liu H; Brannon AR; Reddy AR; Alexe G; Seiler MW; Arreola A; Oza JH; Yao M; Juan D; Liou LS; Ganesan S; Levine AJ; Rathmell WK; Bhanot GV
    BMC Syst Biol; 2010 Apr; 4():51. PubMed ID: 20420713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
    Jung M; Mollenkopf HJ; Grimm C; Wagner I; Albrecht M; Waller T; Pilarsky C; Johannsen M; Stephan C; Lehrach H; Nietfeld W; Rudel T; Jung K; Kristiansen G
    J Cell Mol Med; 2009 Sep; 13(9B):3918-28. PubMed ID: 19228262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA Expression Signatures in Clear Cell Renal Cell Carcinoma: High-Throughput Searching for Key miRNA Markers in Patients from the Volga-Ural Region of Eurasian Continent.
    Gilyazova I; Ivanova E; Izmailov A; Sharifgaliev I; Karunas A; Pudova E; Kobelyatskaya A; Gilyazova G; Izmailova A; Pavlov V; Khusnutdinova E
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma.
    Iwamoto H; Kanda Y; Sejima T; Osaki M; Okada F; Takenaka A
    Int J Oncol; 2014 Jan; 44(1):53-8. PubMed ID: 24212760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
    Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.